Top compounds associated with response to CTB-25J19.1


Feature Type Standardized
Nominal ANOVA
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.036 0.4
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.4
mRNA prima-1 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC -0.049 0.4
mRNA momelotinib CTRPv2 pan-cancer AAC -0.032 0.4
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.034 0.4
mRNA semagacestat CTRPv2 pan-cancer AAC 0.036 0.4
mRNA linifanib CTRPv2 pan-cancer AAC 0.033 0.4
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.4
mRNA neratinib CTRPv2 pan-cancer AAC 0.032 0.4
Download CSV